Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: The 30-year experience at memorial sloan-kettering cancer center

Cancer

Volumn 98, Issue 6, 2003, Pages 1283-1291

  Mora, Jaume ^a,b   Filippa, Daniel A ^a   Qin, Jing ^a   Wollner, Norma ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b HOSPITAL SANT JOAN DE DÉU   (Spain)

Author keywords

Acute lymphoblastic leukemia (ALL); Diffuse lymphoblastic lymphoma (DLBL); LSA2 L2 protocol; Non Hodgkin lymphoma (NHL)

Indexed keywords

ASPARAGINASE; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; HYDROXYUREA; METHOTREXATE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER STAGING; CHILD; CHILDHOOD CANCER; FEMALE; FOLLOW UP; HUMAN; LYMPHOBLASTOMA; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; METASTASIS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROPHYLAXIS; RADIATION DOSE; SECOND CANCER; SURVIVAL RATE; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LYMPHOMA, LYMPHOBLASTIC; LYMPHOMA, NON-HODGKIN; MALE; METHOTREXATE; NEOPLASM STAGING; PREDNISONE; PROGNOSIS; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE;

EID: 0042918122     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11615     Document Type: Article

References (67)

1. Rosenberg SA, Diamond HD, Craver LL, et al. Lymphosarcoma: the effects of therapy and survival in 1,269 patients in a review of 30 years experience. Ann Intern Med. 1960;53:877-897.
2. Bailey RJ Jr., Burgert O Jr., Dahlin DC. Malignant lymphoma in children. Pediatrics. 1961;28:985-992.
3. Lemerle M, Gerard-Marchant R, Sarrazin D, et al. Lymphosarcoma and reticulum cell sarcoma in children. Cancer. 1973;6:1499-1507.
4. Wollner N, Burchenal JH, Lieberman PH, Exelby P, D'Angio G, Murphy ML. Non-Hodgkin's lymphoma in children. A comparative study of two modalities of therapy. Cancer. 1976;37(1):123-134.
5. Wollner N, Exelby PR, Lieberman PH. Non-Hodgkin's lymphoma in children. A progress report on the original patients treated with the LSA2-L2 protocol. Cancer. 1979;44:1990-1999.
6. Reiter A, Schrappe M, Ludwig W-D, et al. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood. 2000;95:416-421.
7. Grovas A, Fremgen A, Raugh A, et al. The National Cancer Data Base report on patterns of childhood cancers in the United States. Cancer. 1997;80:2321-2332.
8. Stansfeld AG, Diebold J, Noel H, et al. Updated Kiel classification for lymphomas [letter]. Lancet. 1988;1:292-293.
9. Filippa DA, Lieberman PH, Erlandson RA, et al. A study of malignant lymphoma using light and ultramicroscopic, cytochemical and immunologic techniques. Correlation with clinical features. Am J Med. 1978;64:259-264.
10. Erlandson RA. Ancillary procedures for evaluation in diagnostic transmission electron microscopy of tumors with clinicopathological, immuno-histochemical and cytogenetic correlations. New York: Raven Press, 1984.
11. Wollner N, Mandell L, Filippa D, Exelby P, McGowan N, Lieberman P. Primary nasal-paranasal oropharyngeal lymphoma in the pediatric age group. Cancer. 1990;65(6):1438-1444.
12. George SL, Aur RV, Mauer AM, Simore JV. A reappraisal of the results of stopping therapy in childhood leukemia. N Engl J Med. 1979;300(6):269-273.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
14. Heller G, Venkatraman ES. Resampling procedures to compare two survival distributions in the presence of right-censored data. Biometrics. 1996;52:1204-1213.
15. Bradstock KF, Kerr A. Immunological detection of covert leukemic spread in mediastinal T-cell lymphoblastic lymphoma. Leuk Res. 1985;9(7):905-911.
16. Jones B, Klingsberg WG. Lymphosarcoma in children. J Pediatr. 1963;63:11-20.
17. Aur RJA, Hustu HO, Simone JV, Pratt CB, Pinkel D. Therapy of localized and regional lymphosarcoma of childhood. Cancer. 1971;6:1328-1331.
18. Cooke Jean V. Mediastinal tumor in acute leukemia. A clinical and roentgenologic study. Am J Dis Child. 1932;44:1153-1177.
19. Lowenbraun S, Sutherland JC, Feldman MJ, Serpick AA. Transformation of reticulum cell sarcoma to acute leukemia. Cancer. 1971;3:579-585.
20. Watanabe A, Sullivan MP, Sutow WW, Wilbur JR. Undifferentiated lymphoma, non-Burkitt's type. Meningeal and bone marrow involvement in children. Am J Dis Child. 1973;125:57-61.
21. 2 therapy in children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded). Cancer. 1985;55:323-336.
22. Hoogstraten B, Owens AH, Lenhard RE, et al. Combination chemotherapy in lymphosarcoma and reticulum cell sarcoma. Blood. 1969;33:370-378.
23. Haghbin M, Tan CC, Clarkson BD, Mike V, Burchenal JH, Murphy ML. Intensive chemotherapy in children with acute lymphoblastic leukemia (L-2 protocol). Cancer. 1974;33:1491-1498.
24. Bruce WR, Meeker BE. Comparison of sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo. J Natl Cancer Inst. 1966;37:233-245.
25. De Vita VT, Schein PS. The use of drugs in combination for the treatment of cancer. N Engl J Med. 1973;288(19):998-1006.
26. Amylon MD, Shuster J, Pullen J, et al. Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. Leukemia. 1999;13:335-342.
27. Sartorelli BD. Clinical applications of cell cycle kinetics. In: Sartorelli A, Johns DG, editors. Handbook of experimental pharmacology, Volume 38. New York: Springer-Verlag, 1974:156-193.
28. 2 therapy in 26 children with non-Hodgkin's lymphoma. Cancer. 1982;50:2740-2746.
29. 2 protocol treatment of stage IV non-Hodgkin's lymphoma in children with partial and extensive bone marrow involvement. Cancer. 1983;52:39-43.
30. 2 therapy in children with high-risk acute lymphoblastic leukemia and non-Hodgkin's lymphoma. Hamatol Bluttransfus. 1983;28:62-67.
31. Samuelsson BO, Ridell B, Rockert L, Gustafsson G, Marky I. Non-Hodgkin lymphoma in children: a 20-year population-based epidemiologic study in western Sweden. J Pediatr Hematol Oncol. 1999;21(2):103-110.
32. 2 regimen. Am J Pediatr Hematol Oncol. 1980;2:317-320.
33. 2). N Engl J Med. 1983;308:559-565.
34. Hvizdala EV, Berard C, Callihan T, et al. Lymphoblastic lymphoma in children - a randomized trial comparing LSA2-L2 with the ACOP+ therapeutic regimen: a Pediatric Oncology Group study. J Clin Oncol. 1988;6:26-33.
35. 2 therapy for childhood lymphoblastic lymphoma [letter]. J Clin Oncol. 1993;11(10):2054-2055.
36. Wagner HP, Dingeldein-Bettler I, Berchtold W, et al. Childhood NHL in Switzerland: incidence and survival of 120 study and 42 non-study patients. Med Pediatr Oncol. 1995;24:281-286.
37. Tubergen DG, Krailo MD, Meadows AT, et al. Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Children's Cancer Group study. J Clin Oncol. 1995;13:1368-1376.
38. 2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Children's Cancer Group. J Clin Oncol. 1993;11:1024-1032.
39. Burkitt D. Long-term remissions following one and two dose chemotherapy for African lymphoma. Cancer. 1967;20(5):756-759.
40. Djerassi I, Kim JS. Methotrexate and citrovorum factor rescue in the management of childhood lymphosarcoma and reticulum cell sarcoma (Non-Hodgkin's lymphomas). Cancer. 1976;38:1043-1051.
41. Gout-Lemerle M, Rodary C, Sarrazin D. Le traitement des lymphomes malins non hodgkiniens de l'enfant. Arch Fr Pediatr. 1976;33:537-553.
42. Ziegler JL. Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience. N Engl J Med. 1977;297:75-80.
43. Hayes DM, Pajak TF, Rege V, et al. Combination chemotherapy for non-Hodgkin's lymphomas: a ten year follow-up study. Med Pediatr Oncol. 1979;6:23-38.
44. Ziegler JL. Burkitt's lymphoma. N Engl J Med. 1981;305:734-745.
45. Carabell SC, Cassady JR, Weinstein HJ, Jaffe N. The role of radiation therapy in the treatment of pediatric non-Hodgkin's lymphoma. Cancer. 1978;42:2193-2205.
46. Patte C, Rodary C, Sarrrazin D, Bernard A, Lemerle J. Resultats du traitement de 178 lymphomes malins non-Hodgkiniens de l'enfant de 1973 a 1978. Arch Fr Pediatr. 1981;38:321-327.
47. Sallan SE, Ritz J, Pesando J, et al. Cell surface antigens: prognostic implications in childhood acute lymphoblastic leukemia. Blood. 1980;55:395-401.
48. Greaves MF. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia. Cancer Res. 1981;41:4752-4763.
49. 2 treatment in 53 children with E-rosette-positive T-cell leukemia: results and prognostic factors (POG study). Blood. 1982;60:1159-1168.
50. Shuster JJ, Falletta JM, Pullen DJ, et al. Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood. 1990;75:166-173.
51. Falletta JM, Shuster JJ, Crist WM, et al. Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study. Leukemia. 1992;6(6):541-546.
52. Murphy SB, Hustu HO. A randomized trial of combined modality therapy of childhood non-Hodgkin's lymphoma. Cancer. 1980;45:630-637.
53. Link MP, Donaldson SS, Berard CW, Shuster JJ, Murphy SS. Results of treatment of childhood localized non-Hodgkin's lymphoma with combination chemotherapy with or without radiotherapy. N Engl J Med. 1990;322:1169-1174.
54. Wollner N, Lane JM, Marcove RC, et al. Primary skeletal non-Hodgkin's lymphoma in the pediatric age group. Med Pediatr Oncol. 1992;20:506-513.
55. Wollner N, Exelby P, Lindsley KL, Lieberman P, Filippa D, Heller G. Primary peripheral nodal lymphoma in children. Cancer. 1993;71:3670-3679.
56. Steinherz PG, Redner A, Steinherz L, Meyers P, Tan C, Heller G. Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. The Memorial Sloan-Kettering-New York II protocol. Cancer. 1993;72:3120-3130.
57. Suryanarayan K, Shuster JJ, Donaldson SS, Hutchison RE, Murphy SB, Link MP. Treatment of localized primary non-Hodgkin's lymphoma of bone in children: a Pediatric Oncology Group study. J Clin Oncol. 1999;17:456-459.
58. Jenkin RD. Radiation in the treatment of non-Hodgkin's lymphoma. Semin Oncol. 1977;4:311-315.
59. Mandell LR, Wollner N, Fuks Z. Is cranial radiation necessary for CNS prophylaxis in pediatric NHL? Int J Radiat Oncol Biol Phys. 1986;13:359-363.
60. 2 protocol with high dose methotrexate, on 84 children with non-B cell (lymphoblastic) lymphoma. Med Pediatr Oncol. 1992;20:105-113.
61. Reiter A, Schrappe M, Ludwig W-D, et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFL 86. Blood. 1994;84:3122-3133.
62. Van den Berg H, Zsiros J, Veneberg A, et al. Favorable outcome after 1-year treatment of childhood T-cell lymphoma/T-cell acute lymphoblastic leukemia. Med Pediatr Oncol. 1998;30:46-51.
63. Steinherz PG, Gaynon PS, Breneman JC, et al. Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features. Cancer. 1998;82:600-612.
64. 2 protocols. Cancer. 1988;62:240-250.
65. Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst. 2001;93:618-629.
66. Neglia JP, Meadows AT, Robison LL, et al. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med. 1991;325:1330-1336.
67. Nygaard R, Garwicz S, Haldorsen T, et al. Second malignant neoplasms in patients treated for childhood leukemia. A population-based cohort study from the Nordic countries. The Nordic Society of Pediatric Oncology and Hematology (NOPHO). Acta Paediatr Scand. 1991;80:1220-1228.